The patients who tend to benefit most from GLP-1 medications (oral or injectable) share certain characteristics: theyve usually tried behavioral approachesimproved diet, increased exercise, better sleepwithout achieving meaningful or sustainable weight loss
When to reassess If GI symptoms worsen instead of improving over the first 2-3 weeks, if any unusual symptom appears, or if blood glucose readings drop more than expected, pause and consult a qualified clinician
They slow gastric emptying, increase feelings of fullness, and reduce food intake, typically resulting in significant weight reduction over several months
GLP-1 receptor agonists slow down gastric emptying, which can reduce how much digoxin is absorbed into the bloodstream
More importantly, a large-scale 3b-phase randomized controlled trial (SURMOUNT-5), which compared semaglutide with tirzepatide in 751 obese adults without type 2 diabetes, explicitly reported that male patients had an average weight loss approximately 6 percentage points lower than female patients after 72 weeks of semaglutide treatment, further verifying that sex is an independent factor affecting semaglutides efficacy [80]